SYDNEY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company) the Company developing a new class of synthetic anti-infectives, today announced it was ...

Most patent claims are as broad as possible, and filed down in an iterative process.

Enlivex Therapeutics Ltd. (ENLV) is making significant progress in immunotherapy with its innovative Allocetra™ technology.

Japan is the third-largest pharmaceutical market globally and accounts for approximately 5% of the total pharmaceutical sector. The country’s antibiotic resistance market is projected to reach ...

Interestingly, Games Fray also highlights another Nintendo U.S. patent (18/652,883), which was actually filed back in ...

In September of last year, and in light of a corresponding Japanese patent infringement suit, I published an article ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Acurx Pharmaceuticals’ DNA Polymerase IIIC Inhibitors receives Japanese patent: Staten Island, New York Thursday, February 20, 2025, 18:00 Hrs [IST] Acurx Pharmaceuticals, Inc., ...

To date, Acurx has obtained three U.S. patents, one Israeli patent and now one Japanese patent, in each case, which cover the ACX-375C program, relating to DNA Polymerase IIIC Inhibitors ...

The Philippines and Japan have partnered to intensify the country’s efforts to combat counterfeit goods, especially in identifying fake Japanese products in the local market. In a statement Monday, ...